Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Cencora
NYSE:COR Community
1
Narratives
written by author
0
Comments
on narratives written by author
30
Fair Values set
on narratives written by author
Create a narrative
Cencora
Popular
Undervalued
Overvalued
Cencora
WA
Analyst Price Target
Consensus Narrative from 15 Analysts
Investments In Logistics And Data-Driven Insights Will Improve Future Operational Efficiencies
Key Takeaways Expanding specialty pharmaceuticals and strategic partnerships aim to enhance customer relations and drive revenue growth. International expansion and automation in Europe boost business continuity and operational efficiencies for global revenue growth.
View narrative
US$269.48
FV
10.4% undervalued
intrinsic discount
7.19%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
23 days ago
author updated this narrative
Your Valuation for
COR
Cencora
Your Fair Value
US$
Current Price
US$241.43
15.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-3b
420b
2015
2018
2021
2024
2025
2027
2030
Revenue US$420.3b
Earnings US$1.9b
Advanced
Set as Fair Value